TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

Benzinga Newsdesk www.benzinga.com Positive 71.6%

Neg 0% Neu 0% Pos 71.6%

TD Cowen analyst Ryan Langston maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $125 to $140.